Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-09-22, Stock:JNJ, The news for the past five days is as follows:
2020-09-15: NEWS1: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS2: Coronavirus update: Trump says vaccine ready within weeks; Pfizer says some patients show side effects.NEWS3: US government must rebuild trust in the FDA: top doctor.NEWS4: Trump says COVID-19 vaccine will be ready within 'weeks'.NEWS5: Some volunteers quit J&J COVID-19 trial in Spain after AstraZeneca scare: investigator.NEWS6: AstraZeneca resumes COVID-19 vaccine trials in South Africa, health dept says.NEWS7: Some back out of J&J COVID-19 vaccine trial in Spain after AstraZeneca scare, lead investigator says.NEWS8: Dow jumps 175 points on gains for shares of Apple Inc., Dow Inc..
2020-09-16: NEWS1: Johnson & Johnson stock falls Wednesday, still outperforms market.NEWS2: Cos. with a real vaccine history will have their data sets in early 2021: Expert.NEWS3: 3 Steady Stocks to Buy in a Highly Volatile Market.
2020-09-17: NEWS1: EXPLAINER-When will COVID-19 vaccines be generally available in the U.S.?.NEWS2: New York Files Charges Against Johnson & Johnson Over Opioid Marketing.NEWS3: Economic recovery won’t come until we get Americans to feel safe: Ric Edelman.NEWS4: Infectious Diseases Physician on COVID-19 vaccine outlook: 'It’s less about what’s the exact date, but making sure it’s effective'.NEWS5: Johnson & Johnson stock underperforms Thursday when compared to competitors.NEWS6: FOCUS-Pfizer vaccine trial bets on early win against coronavirus, documents show.NEWS7: Johnson & Johnson Faces New York State Insurance Fraud Action Linked to Opioid Crisis.NEWS8: Race for a COVID-19 vaccine continues, here's what you need to know.NEWS9: New York charges Johnson & Johnson with insurance fraud over opioid claims.
2020-09-18: NEWS1: Johnson & Johnson stock outperforms competitors on strong trading day.NEWS2: First Psychedelic Drug Stock Hits $1 Billion In Debut After Upsized IPO.NEWS3: EXPLAINER-When will COVID-19 vaccines be generally available in the U.S.?.NEWS4: Three-quarters of Americans are worried about the vaccine rush: Pew.NEWS5: The First Psychedelic Drug Stock Jumps In Debut After Upsized IPO.NEWS6: Dow Jones Extends Losses As Apple Drops; Nasdaq Falls Deeper In The Red.NEWS7: EXPLAINER-When will COVID-19 vaccines be generally available in the U.S.?.NEWS8: Price Over Earnings Overview: Johnson & Johnson.NEWS9: Why Novartis’ Absence From the Covid-19 Vaccine Race Is a Benefit.NEWS10: Moderna CEO downplays vaccine timeline pressure: 'We don't want the first, we want the best'.NEWS11: These 3 Dividend Aristocrats Will Shield You From Another Market Crash.NEWS12: How Much Of Johnson & Johnson (NYSE:JNJ) Do Institutions Own?.NEWS13: 3 Coronavirus Vaccines in Phase 3 Clinical Studies: How They Stack Up Against Each Other.NEWS14: 20/20 GeneSystems Stock: Leveraging AI for More Accurate Cancer Screening.NEWS15: Johnson & Johnson Downplayed Opioid Drugs' Side Effects, New York Unveils Charges.
2020-09-21: NEWS1: Illumina Announces $8 Billion Acquisition Of Former Cancer-Testing Spinoff Grail.NEWS2: Johnson & Johnson stock falls Monday, underperforms market.NEWS3: Instead of Going Public, Cancer-Testing Spinoff Grail Is Returning to Illumina.NEWS4: Anticancer Drug Team-Ups Show Promise. 4 Stocks That Stand to Gain..NEWS5: Trump suggests Pfizer could win U.S. COVID-19 vaccine approval, JNJ to come later.NEWS6: Why Legend Biotech Stock Is Sinking Today.

Answer: Decrease